Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.

Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial. Int J Cardiol. 2019 Mar 01; 278:217-222.

View in: PubMed

subject areas

Adenosine Monophosphate
Aged
Double-Blind Method
Female
Heart Diseases
Humans
Male
Middle Aged
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
ST Elevation Myocardial Infarction
Thrombosis
Treatment Outcome

authors with profiles

Robert Harrington